M&T BANK CORP false 0000036270 0000036270 2025-07-30 2025-07-30 0000036270 us-gaap:CommonStockMember 2025-07-30 2025-07-30 0000036270 mbt:PerpetualFixedToFloatingRateNonCumulativePreferredStockSeriesHMember 2025-07-30 2025-07-30 0000036270 mbt:PerpetualFixedToFloatingRateNonCumulativePreferredStockSeriesJMember 2025-07-30 2025-07-30
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 30, 2025

 

 

M&T BANK CORPORATION

(Exact name of registrant as specified in its charter)

 

 

New York

(State or other jurisdiction of incorporation)

 

1-9861   16-0968385
(Commission File Number)   (I.R.S. Employer Identification No.)
One M&T Plaza, Buffalo, New York   14203
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (716) 635-4000

 

(NOT APPLICABLE)

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

 

Trading
Symbols

 

Name of Each Exchange

on Which Registered

Common Stock, $.50 par value   MTB   New York Stock Exchange
Perpetual Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series H   MTBPrH   New York Stock Exchange
Perpetual Fixed Rate Non-Cumulative Preferred Stock Series J   MTBPrJ   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 8.01.

Other Events.

On July 30, 2025, M&T Bank Corporation (“M&T”) closed the public offering of $750,000,000 aggregate principal amount of its 5.400% Fixed Rate Reset Subordinated Notes, Series B, due July 30, 2035 (the “Subordinated Notes”). The Subordinated Notes have been registered under the Securities Act of 1933, as amended, by a registration statement on Form S-3 (File No. 333-274646) filed by M&T with the Securities and Exchange Commission (the “Registration Statement”). The legal opinion of Squire Patton Boggs (US) LLP, as counsel to M&T, regarding the issuance and sale of the Subordinated Notes, is filed with this Current Report on Form 8-K and shall be incorporated by reference into the Registration Statement.

 

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit
No.

  

Description of Exhibit

 5.1    Opinion of Squire Patton Boggs (US) LLP as to the validity of the Subordinated Notes.
23.1    Consent of Squire Patton Boggs (US) LLP (included in Exhibit 5.1).
104    The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    M&T Bank Corporation
Date: July 30, 2025      
    By:  

/s/ Daryl N. Bible

    Name:   Daryl N. Bible
    Title:   Senior Executive Vice President and Chief Financial Officer